Atmanirbhar Bharat is an aspirational ideal well worth pursuing, but not without a sustained quality control framework in place. Time and again, there have been serious threats to the goal of ‘making in India’, particularly in the pharmaceutical sector. The issue of quality of cough syrups has repeatedly been raised, and India with great ambitions in the global pharmaceutical sector has often been short of what is required to build a robust and trustworthy industry. Recently, the Union Health Ministry sought strict drug compliance from all Indian drug manufacturers, in line with the revised Schedule M norms for pharmaceutical products in India. This came after a report from the Tamil Nadu Drugs Control Department found above permissible limits of diethylene glycol (DEG) in samples of Col

See Full Page